SG Americas Securities’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,284
| Closed | -$59K | – | 3182 |
|
|
2025
Q1 | $59K | Sell |
13,284
-4,445
| -25% | -$19.7K | ﹤0.01% | 2823 |
|
|
2024
Q4 | $139K | Buy |
17,729
+4,163
| +31% | +$32.6K | ﹤0.01% | 2204 |
|
|
2024
Q3 | $178K | Buy |
+13,566
| New | +$178K | ﹤0.01% | 2307 |
|
|
2024
Q2 | – | Sell |
-11,963
| Closed | -$195K | – | 2883 |
|
|
2024
Q1 | $195K | Sell |
11,963
-9,596
| -45% | -$156K | ﹤0.01% | 1770 |
|
|
2023
Q4 | $147K | Buy |
21,559
+3,210
| +17% | +$21.9K | ﹤0.01% | 2224 |
|
|
2023
Q3 | $100K | Buy |
+18,349
| New | +$100K | ﹤0.01% | 2532 |
|
|
2023
Q2 | – | Sell |
-21,735
| Closed | -$109K | – | 2900 |
|
|
2023
Q1 | $109K | Buy |
21,735
+11,676
| +116% | +$58.6K | ﹤0.01% | 2605 |
|
|
2022
Q4 | $49K | Sell |
10,059
-6,483
| -39% | -$31.6K | ﹤0.01% | 2571 |
|
|
2022
Q3 | $239K | Sell |
16,542
-1,675
| -9% | -$24.2K | ﹤0.01% | 1930 |
|
|
2022
Q2 | $276K | Buy |
+18,217
| New | +$276K | ﹤0.01% | 2220 |
|
|
2022
Q1 | – | Sell |
-15,020
| Closed | -$243K | – | 3032 |
|
|
2021
Q4 | $243K | Sell |
15,020
-10,790
| -42% | -$175K | ﹤0.01% | 2317 |
|
|
2021
Q3 | $737K | Buy |
25,810
+374
| +1% | +$10.7K | ﹤0.01% | 1994 |
|
|
2021
Q2 | $860K | Sell |
25,436
-3,730
| -13% | -$126K | ﹤0.01% | 1503 |
|
|
2021
Q1 | $882K | Sell |
29,166
-27,546
| -49% | -$833K | ﹤0.01% | 1486 |
|
|
2020
Q4 | $2.81M | Sell |
56,712
-20,774
| -27% | -$1.03M | 0.02% | 748 |
|
|
2020
Q3 | $2.98M | Buy |
77,486
+72,163
| +1,356% | +$2.77M | 0.02% | 418 |
|
|
2020
Q2 | $230K | Sell |
5,323
-210
| -4% | -$9.07K | ﹤0.01% | 2357 |
|
|
2020
Q1 | $144K | Buy |
5,533
+2,151
| +64% | +$56K | ﹤0.01% | 2317 |
|
|
2019
Q4 | $106K | Buy |
+3,382
| New | +$106K | ﹤0.01% | 2520 |
|